Wednesday, August 03, 2005 7:24:37 PM
Can someone please explain to me why there is so much discussion on market related technicalities involving a non-reporting pink sheet company? It all means nothing except that there are some MM’s propping up the stock. There are no fundamentals associated with this company that are verified by anyone or even checked by the MM’s, as this would violate insider rules. The point is no one but their accountant knows, and he ain’t talking. If you sincerely believe that NWAU, or whoever they end up being, is going to book $8 million in profit next year, you need professional help. If management does an incredible job, at best they’re going to break even and I would not bet on that outcome. Also, if and when they become reporting, you have seen your last earnings guidance form these guys. The punishment from the MM’s for missing a forecast would be swift and brutal with no forgiveness.
If you want to talk about something why don’t you pumpers try to do some research on the note lot business to see if there’s ever been, in the history of note lots, the kind of profits they are talking about, generated with their current projected revenue base? And don’t forget the GPS business, which is currently losing money and may only breakeven using their own current projections. When you get your answers, apply the numbers and then look at the fundamentals. I think you will be shocked what it’s costing you to play with this stock. Of course I know none of you will do any of this, you’re going to keep talking about volume, opens, closes and what Scott ate for lunch today, you know, important stuff……Dog
If you want to talk about something why don’t you pumpers try to do some research on the note lot business to see if there’s ever been, in the history of note lots, the kind of profits they are talking about, generated with their current projected revenue base? And don’t forget the GPS business, which is currently losing money and may only breakeven using their own current projections. When you get your answers, apply the numbers and then look at the fundamentals. I think you will be shocked what it’s costing you to play with this stock. Of course I know none of you will do any of this, you’re going to keep talking about volume, opens, closes and what Scott ate for lunch today, you know, important stuff……Dog
Recent FITY News
- Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health • ACCESS Newswire • 04/15/2026 12:30:00 PM
- Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market • ACCESS Newswire • 04/14/2026 12:30:00 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • GlobeNewswire Inc. • 01/05/2026 06:08:59 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • InvestorsHub NewsWire • 01/05/2026 06:00:00 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • GlobeNewswire Inc. • 10/09/2025 02:23:35 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • InvestorsHub NewsWire • 10/09/2025 02:00:00 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • GlobeNewswire Inc. • 09/30/2025 01:56:45 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • InvestorsHub NewsWire • 09/30/2025 01:45:00 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • GlobeNewswire Inc. • 09/23/2025 01:07:25 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • InvestorsHub NewsWire • 09/23/2025 12:35:36 PM
- Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 • InvestorsHub NewsWire • 08/26/2025 01:00:00 PM
- Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing • InvestorsHub NewsWire • 08/22/2025 02:30:00 PM
- Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership • InvestorsHub NewsWire • 07/29/2025 01:00:00 PM
- Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières • InvestorsHub NewsWire • 07/28/2025 12:30:00 PM
- Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • InvestorsHub NewsWire • 07/17/2025 12:30:00 PM
- Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • InvestorsHub NewsWire • 07/10/2025 12:30:49 PM
- Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • InvestorsHub NewsWire • 07/08/2025 12:30:00 PM
